OncoSil Medical LtdASX: OSL

OncoSil AGM CEO Presentation

· Issued by OncoSil Medical Ltd

Filed with ASX · · 39 pages · English

Sydney, Australia – 29 October 2019: OncoSil Medical Ltd (ASX: OSL) (OncoSil or the Company), a medical device company focused on localised treatments for patients with pancreatic and liver cancer, has released its CEO presentation for the Annual General Meeting of OncoSil shareholders to be held at 11:00am AEDT today. About OncoSil OncoSil Medical is a medical device company seeking to advance ra

OncoSil Medical Ltd on 6ix

In the deck

Story so far

Earlier from OncoSil Medical

Later from OncoSil Medical

All OncoSil Medical news releases